ArticleScientific reports2025
Non-small cell lung cancer subtype classification based on cross-scale multi-instance learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A CLIP-based framework for multiclass lung histopathology classification with prompt engineering and class-imbalance-aware focal optimization.Scientific reports · 2026Article
- Encoding functional edges in graphs to model spatially varying relationships in the tumor microenvironment.NPJ artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), the two major subtypes of non-small cell lung cancer (NSCLC), present significant diagnostic challenges with direct implications for treatment planning. In this study, we propose a novel multi-instance learning (MIL) pathological image classification model that incorporates an additive attention mechanism and a new category classifier to enhance subtype discrimination. The model further integrates a cross-scale focal region detection strategy to improve sensitivity to key histological features. Trained on the Cancer Genome Atlas (TCGA) dataset, our model achieved a subtype classification accuracy (ACC) of 97.0% and an area under the ROC curve (AUC) of 0.978, outperforming state-of-the-art methods including ABMIL, CLAM, DS-MIL, DTFD-MIL, FR-MIL, and WIKG-MIL across multiple evaluation metrics. Ablation studies validate the contribution of each module to overall performance improvement. Generalization experiments conducted on the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Cancer Imaging Archive (TCIA) Lung dataset and an external dataset from Yantai Yuhuangding Hospital demonstrate the robustness of our model, achieving ACCs of 91.2% and 93.0%, and AUCs of 0.967 and 0.968, respectively. These results underscore the model's strong generalization ability and its potential as a reliable tool for accurate NSCLC subtype classification across diverse clinical scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.